Skip to content

FARAPOINT™ M004PF81M110Recalls & reported problems

Boston Scientific Corporation · Pulsed Field Ablation Catheter · Class 3

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
1
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00191506047207), received between Sep 18, 2026 and Sep 30, 2026 — classified as 1 death, 2 malfunctions.

The most frequently reported specific device problem is “Connection Problem” (2 reports).

5 other recalls cover devices cleared under the same FDA submission (P230030); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 3 reportsOct 2026: 0 reports2024202520263
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Connection Problem2
  • Failure to Sense1
  • Off-Label Use1

Patient problems

  • No Clinical Signs, Symptoms or Conditions2
  • Bradycardia1
  • Cardiac Arrest1
  • Low Blood Pressure/ Hypotension1
  • Pain1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • MalfunctionSep 30, 2026Failure to Sense; Connection Problem

    It was reported that during an ablation procedure a FARAPOINT was selected for use. During procedure, the catheter could not get connected for pacing due to recording system connection. Troubleshooting was attempted, including, reconnecting again and checking pinning, however, the issue persisted. The procedure was cancelled.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50947811 ↗
  • MalfunctionSep 30, 2026Connection Problem

    It was reported that during an ablation procedure a FARAPOINT was selected for use. During procedure, the catheter was connected, no signals were shown on mapping system or recording system, tried exiting study and looked at pinning. The catheter was replaced. The procedure was cancelled.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50947810 ↗
  • DeathSep 18, 2026Off-Label Use

    It was reported that the patient experienced bradycardia, hypotension, and cardiac arrest after the procedure. The patient died.During a cavotricuspid isthmus (CTI) ablation procedure to treat atrial flutter a FARAPOINT catheter was used. Use of the FARAPOINT catheter to treat atrial flutter constituted off-label use of the device per the Instructions For Use (IFU). Groin access was obtained under ultrasound guidance. The coronary sinus catheter and intracardiac echocardiography (ICE) catheter were placed, then the FARAPOINT catheter was inserted and advanced to the right atrium (RA). Mapping was performed with the FARAPOINT catheter before it was positioned at the TV annulus to begin ablation. 500mcg of intravenous (IV) nitroglycerin was administered prior to beginning ablation. Seventeen ablation applications were made under ICE and 3D mapping guidance. There were no ST segment changes observed on the 12-lead electrogram (ECG) while the procedure was ongoing. The procedure was completed and the patient was taken to the Post Anesthesia Care Unit (PACU) for recovery prior to being sent back to their inpatient room. Overnight the patient became bradycardic, hypotensive, and went int

    Patient problems: Bradycardia; Cardiac Arrest; Low Blood Pressure/ Hypotension; Pain

    MAUDE report 50818605 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under P230030. One submission often covers many models, so check the product and lot details in each record.

  • Z-2753-2026 · Jun 11, 2026 · Open, Classified
    FARASTAR Ablation Generator EU, Pulsed Field Ablation Generator, Product ID 61M401; Percutaneous Cardiac Ablation Catheter
  • Z-2752-2026 · Jun 11, 2026 · Open, Classified
    FARASTAR PFA Generator, Product ID M004PFCE61M460; Percutaneous Cardiac Ablation Catheter
  • Z-2750-2026 · Jun 11, 2026 · Open, Classified
    FARASTAR Ablation Generator EU, Pulsed Field Ablation Generator, Product ID 61M401; Percutaneous Cardiac Ablation Catheter
  • Z-2751-2026 · Jun 11, 2026 · Open, Classified
    FARASTAR Pulsed Field Ablation Generator, Product ID M004PFCE61M401; Percutaneous Cardiac Ablation Catheter
  • Z-2278-2025 · Jun 25, 2025 · Open, Classified
    FARAWAVE 1.0 Pulsed Field Ablation Catheter, Product ID M004PF41M401

Other Percutaneous Cardiac Ablation Catheter for Treatment of Atrial Fibrillation with Irreversible Electroporation devices

All Percutaneous Cardiac Ablation Catheter for Treatment of Atrial Fibrillation with Irreversible Electroporation devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page